Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06357195 · ClinicalTrials.gov registry record
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
A clinical trial of Aging and Movement Disorders, sponsored by Ohio State University.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06357195 is a study of Aging and Movement Disorders that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 1,000 participants, below the 2,191-participant average among 262 other Aging trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06357195, a study of Aging and Movement Disorders, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about current practices for the acute neuropsychiatric management of older adults during emergency department (ED) visits. Researchers will compare current standard of care practices with implemented guideline practice to see if standardized medication guidelines help reduce the usage of antipsychotics and/or benzodiazepines during acute presentations. The main questions this study aims to answer are: * How many older adults are receiving antipsychotics or benzodiazepines during emergency department visits? * Why are older adults receiving antipsychotics or benzodiazepines during emergency department visits? * How many older adults who receive antipsychotics or benzodiazepines during emergency department visits have an underlying cognitive or movement disorder? * What effects does administration of antipsychotics or benzodiazepines during emergency department visits have on patient outcomes in older adults and adults with neurocognitive disorders? * Does implementation of standardized medication guidelines help reduce the usage of antipsychotics and/or benzodiazepines during acute presentations?
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06357195
The ClinicalTrials.gov registry entry for NCT06357195 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,191-participant average among 262 other Aging trials with a reported enrollment target (54% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Aging appearing as the primary indexed condition, and to 0 interventions.
NCT06357195 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06357195 about?
NCT06357195 is a clinical study titled "DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients". The goal of this observational study is to learn about current practices for the acute neuropsychiatric management of older adults during emergency department (ED) visits. Researchers will compare current standard of care practices with implemented guideline practice to see if standardized medicatio...
What is the current status of trial NCT06357195?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2024-07-01. Estimated completion is 2026-07-01.
What conditions does trial NCT06357195 study?
This clinical trial studies the following conditions: Aging, Movement Disorders, Behavior, Dementia With Lewy Bodies, Emergency Psychiatric.
Who is sponsoring clinical trial NCT06357195?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06357195 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.